secwatch.observer — SEC 8-K summary
======================================

Issuer:     Clearside Biomedical, Inc. (CLSDQ)
CIK:        0001539029
Form:       8-K
Filed at:   2024-02-08T23:59:59+00:00
Accession:  0001193125-24-028487
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Clearside Biomedical prices $15M registered direct offering of 11.1M shares and warrants
--------------------------------------------------------------------------------

- Gross proceeds ~$15M from sale of 11,111,111 shares and warrants at $1.35 per unit.
- Warrants exercisable at $1.62/share for 5 years from August 2024.
- Offering expected to close February 9, 2024 with Citizens JMP Securities as placement agent.
- Net proceeds for working capital; management says cash runway extends into Q3 2025.
- Placement agent fee of 6.0% of gross proceeds plus reimbursement of expenses.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1539029/000119312524028487/0001193125-24-028487-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1539029/000119312524028487/d754271d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-028487

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer